These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7914534)

  • 1. [New serotonergic ligands with a benzopyran or dioxinopyridine structure: synthesis and activity].
    Guillaumet G
    J Pharm Belg; 1994; 49(3):216-20. PubMed ID: 7914534
    [No Abstract]   [Full Text] [Related]  

  • 2. 3,4-Dihydro-3-amino-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 1. Synthesis and structure--activity relationship studies.
    Podona T; Guardiola-Lemaître B; Caignard DH; Adam G; Pfeiffer B; Renard P; Guillaumet G
    J Med Chem; 1994 Jun; 37(12):1779-93. PubMed ID: 7912735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-amino-3,4-dihydro-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 2. Synthesis and quantitative structure-activity relationship studies of spiro[pyrrolidine- and piperidine-2,3'(2'H)-benzopyrans].
    Comoy C; Marot C; Podona T; Baudin ML; Morin-Allory L; Guillaumet G; Pfeiffer B; Caignard DH; Renard P; Rettori MC; Adam G; Guardiola-Lemaitre B
    J Med Chem; 1996 Oct; 39(21):4285-98. PubMed ID: 8863806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-substituted 3,4-dihydro-3-amino-2H-1-benzopyran derivatives: synthesis and interaction with serotoninergic receptors.
    Rezaie R; Joseph B; Bremner JB; Delagrange P; Kopp C; Misslin R; Pfeiffer B; Renard P; Guillaumet G
    J Pharm Pharmacol; 2001 Jul; 53(7):959-68. PubMed ID: 11480547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory and analgesic activities of some newly synthesized pyridinedicarbonitrile and benzopyranopyridine derivatives.
    Hosni HM; Abdulla MM
    Acta Pharm; 2008 Jun; 58(2):175-86. PubMed ID: 18515227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations on the synthesis and properties of some N-arylpiperazinylalkyl derivatives of imides of 3,4-pyridinedicarboxylic acids.
    Sladowska H
    Farmaco; 1993 Jan; 48(1):85-94. PubMed ID: 8096137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel and selective 5-HT2C/2B receptor antagonists as potential anxiolytic agents: synthesis, quantitative structure-activity relationships, and molecular modeling of substituted 1-(3-pyridylcarbamoyl)indolines.
    Bromidge SM; Dabbs S; Davies DT; Duckworth DM; Forbes IT; Ham P; Jones GE; King FD; Saunders DV; Starr S; Thewlis KM; Wyman PA; Blaney FE; Naylor CB; Bailey F; Blackburn TP; Holland V; Kennett GA; Riley GJ; Wood MD
    J Med Chem; 1998 May; 41(10):1598-612. PubMed ID: 9572885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of tolerance in pigeons to behavioral effects of a new benzopyran derivative.
    Campo RA
    J Pharmacol Exp Ther; 1973 Mar; 184(3):521-7. PubMed ID: 4687218
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-2,3'-bipyridine: a highly potent, orally active metabotropic glutamate subtype 5 (mGlu5) receptor antagonist with anxiolytic activity.
    Roppe JR; Wang B; Huang D; Tehrani L; Kamenecka T; Schweiger EJ; Anderson JJ; Brodkin J; Jiang X; Cramer M; Chung J; Reyes-Manalo G; Munoz B; Cosford ND
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3993-6. PubMed ID: 15225713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel and selective partial agonists of 5-HT3 receptors. 2. Synthesis and biological evaluation of piperazinopyridopyrrolopyrazines, piperazinopyrroloquinoxalines, and piperazinopyridopyrroloquinoxalines.
    Prunier H; Rault S; Lancelot JC; Robba M; Renard P; Delagrange P; Pfeiffer B; Caignard DH; Misslin R; Guardiola-Lemaitre B; Hamon M
    J Med Chem; 1997 Jun; 40(12):1808-19. PubMed ID: 9191957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacological evaluation of N-aryl(pyrimidinyl) piperazinylalkyl (hydroxyalkyl) derivatives of 1,2,3,4-tetra- and 1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazines.
    Sladowska H; Potoczek J; Rajtar G; Sieklucka-Dziuba M; Młynarczyk M; Kleinrok Z
    Farmaco; 1996 Jun; 51(6):431-6. PubMed ID: 8766227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imidazo[4,5-c]pyridines as corticotropin releasing factor receptor ligands.
    Arvanitis AG; Rescinito JT; Arnold CR; Wilde RG; Fitzgerald LW; Zaczek R; Hartig PR; Grossman S; Arneric SP; Gilligan PJ; Olson RE; Robertson DW
    Bioorg Med Chem Lett; 2003 Jan; 13(1):129-31. PubMed ID: 12467632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the synthesis and antiallergic activity of 5H-[1]-benzopyrano[2,3-b]pyridine derivatives].
    Oe T; Tsuruda M; Matsuo H; Terasawa M; Goto K
    Yakugaku Zasshi; 1983 Mar; 103(3):300-12. PubMed ID: 6620130
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis, pharmacological evaluation, and structure-activity relationships of benzopyran derivatives with potent SERM activity.
    Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M; Caruso PL; Galbiati E; Lipreri M; Rivara S; Lodola A; Mor M
    Bioorg Med Chem; 2004 Jul; 12(14):3763-82. PubMed ID: 15210143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The products of aminomethylation of 2,5-dihydroxypyridine.
    Nantka-Namirski P; Rykowski A
    Pol J Pharmacol Pharm; 1973; 25(5):455-9. PubMed ID: 4777349
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis, structure-activity relationships, and in vivo properties of 3,4-dihydro-1H-pyrido[2,3-b]pyrazin-2-ones as corticotropin-releasing factor-1 receptor antagonists.
    Dzierba CD; Takvorian AG; Rafalski M; Kasireddy-Polam P; Wong H; Molski TF; Zhang G; Li YW; Lelas S; Peng Y; McElroy JF; Zaczek RC; Taub RA; Combs AP; Gilligan PJ; Trainor GL
    J Med Chem; 2004 Nov; 47(23):5783-90. PubMed ID: 15509177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of allosteric potentiators for the metabotropic glutamate 2 receptor: synthesis and subtype selectivity of N-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2- trifluoroethylsulfonyl)pyrid-3-ylmethylamine.
    Johnson MP; Baez M; Jagdmann GE; Britton TC; Large TH; Callagaro DO; Tizzano JP; Monn JA; Schoepp DD
    J Med Chem; 2003 Jul; 46(15):3189-92. PubMed ID: 12852748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of the structure of 4, 6-disubstituted 2-(4-alkyl-1-piperazinyl)pyridines: synthesis and their 5-HT2A receptor activity.
    Paluchowska MH; Bojarski AJ; Bugno R; Charakchieva-Minol S; Wesołowska A
    Arch Pharm (Weinheim); 2003 Apr; 336(2):104-10. PubMed ID: 12761763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and preliminary screening of derivatives of 2-(4-arylpiperazin-1-ylalkyl)-3-oxoisothiazolo[5,4-b] pyridines as CNS and antimycobacterial agents.
    Malinka W; Sieklucka-Dziuba M; Rajtar G; Zgodziński W; Kleinrok Z
    Pharmazie; 2000 Jun; 55(6):416-25. PubMed ID: 10907247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two animal models of anxiety--different sensitivity for anxiolytic action of GABAA receptor complex ligands.
    Nazar M; Płaznik A; Jessa M
    Acta Physiol Hung; 1996; 84(4):437-9. PubMed ID: 9328625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.